NYSE · Healthcare · Medical - Healthcare Information Services
Claritev Corporation
CTEV
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. CEO Travis S. Dalton · Market cap $414.8M.
$24.33
-0.70 · -2.80%
52w hi $73.6852w lo $11.50
Off 52w high 46.2%
62
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
8
4 strong · 4 notable
Analyst consensus
Strong Buy
Avg PT $52.00
Section 01
Recent Form 4 filings
24 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 28 | Travis Dalton | Pres., CEO & Executive Chair | Buy | 1,950 | $38.48 | +$75K | 56 |
| Aug 27 | Travis Dalton | Pres., CEO & Executive Chair | Buy | 4,500 | $38.81 | +$175K | 62 |
| May 19 | John Michael Prince | Buy | 10,000 | $16.00 | +$160K | 77 | |
| May 18 | Travis Dalton | Pres., CEO & Executive Chair | Buy | 9,720 | $12.92 | +$126K | 86 |
| May 18 | Travis Dalton | Pres., CEO & Executive Chair | Buy | 11,200 | $11.88 | +$133K | 86 |
| May 18 | Michael Kim | EVP, Chief Digital Officer | Buy | 3,000 | $16.65 | +$50K | 64 |
| Mar 12 | Michael Kim | EVP, Chief Digital Officer | Buy | 15,000 | $16.50 | +$248K | 55 |
| Feb 27 | Travis Dalton | Pres., CEO & Executive Chair | Buy | 15,380 | $13.00 | +$200K | 82 |
| Feb 27 | Michael Kim | EVP, Chief Digital Officer | Buy | 30,000 | $14.30 | +$429K | 72 |
| Nov 20 | Travis Dalton | Pres., CEO & Executive Chair | Buy | 5,290 | $47.23 | +$250K | 72 |
| Nov 17 | Michael Kim | EVP, Chief Digital Officer | Buy | 9,600 | $38.25 | +$367K | 58 |
| Nov 17 | William B. Mintz | SVP, Chief Strategy Officer | Buy | 916 | $38.00 | +$35K | 33 |
| Nov 12 | H&F Corporate Investors VIII, Ltd. | Sell | 264,336 | $48.67 | −$12.86M | 39 | |
| Nov 12 | H&F Corporate Investors VIII, Ltd. | Sell | 66,997 | $48.67 | −$3.26M | 36 | |
| Nov 12 | H&F Corporate Investors VIII, Ltd. | Sell | 20,722 | $48.67 | −$1.01M | 36 | |
| Nov 12 | H&F Corporate Investors VIII, Ltd. | Sell | 354,524 | $48.67 | −$17.25M | 39 | |
| Nov 12 | H&F Corporate Investors VIII, Ltd. | Sell | 789,936 | $48.67 | −$38.44M | 39 | |
| Aug 11 | Travis Dalton | Pres., CEO & Executive Chair | Buy | 3,982 | $58.30 | +$232K | 72 |
| Aug 07 | Jerome Hogge | EVP, Chief Operating Officer | Buy | 5,621 | $53.51 | +$301K | 59 |
| May 19 | Jerome Hogge | EVP, Chief Operating Officer | Buy | 12,500 | $27.94 | +$349K | 72 |
| May 19 | Douglas Michael Garis | EVP&CFO | Buy | 3,600 | $27.73 | +$100K | 63 |
| May 15 | Travis Dalton | Pres., CEO & Executive Chair | Buy | 3,773 | $26.50 | +$100K | 56 |
| May 12 | Douglas Michael Garis | EVP&CFO | Buy | 17,060 | $22.02 | +$376K | 69 |
| May 12 | Douglas Michael Garis | EVP&CFO | Buy | 11,689 | $21.95 | +$257K | 69 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct